Multiple Myeloma Refractory research hub

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

This study is testing a new combination of medicines – inobrodib, pomalidomide, and dexamethasone – for people in the UK with multiple myeloma that has come back and is no longer responding to usual treatments. The aim is to see how well these medicines work together and what side effects they might cause.